IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
NCT04400994
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Pemphigus
Interventions
DRUG:
Rituximab
OTHER:
IVIg
Sponsor
The University of Hong Kong